|Last Price$11.18||Day Change (%)0.72%|
|Open Price$11.18||Day Change ($)0.08|
|Day Range11.18–11.18||52-Week Range10.68–11.18|
As of Fri 06/24/2016 | USD
Epizyme Reports Early Data from Global Phase 2 Trial of Tazemetostat in Non-Hodgkin Lymphoma at ASH Lymphoma Biology Meeting
Credit default swap provider Primus Guaranty PRS reported fourth-quarter net economic results 19% above the fourth quarter of last year. It's important to differentiate net economic results from reported net income for Primus since the latter contains mark-to-market accounting of swaps, which ...